Transcenta Holding Limited (6628.HK)

HKD 0.6

(0.0%)

Total Liabilities Summary of Transcenta Holding Limited

  • Transcenta Holding Limited's latest annual total liabilities in 2023 was 665.66 Million CNY , up 0.76% from previous year.
  • Transcenta Holding Limited's latest quarterly total liabilities in 2024 Q2 was 571.24 Million CNY , down 0.0% from previous quarter.
  • Transcenta Holding Limited reported annual total liabilities of 660.64 Million CNY in 2022, up 14.03% from previous year.
  • Transcenta Holding Limited reported annual total liabilities of 579.38 Million CNY in 2021, down -80.07% from previous year.
  • Transcenta Holding Limited reported quarterly total liabilities of 571.24 Million CNY for 2024 Q2, down 0.0% from previous quarter.
  • Transcenta Holding Limited reported quarterly total liabilities of 665.66 Million CNY for 2023 Q4, down 0.0% from previous quarter.

Annual Total Liabilities Chart of Transcenta Holding Limited (2023 - 2019)

Historical Annual Total Liabilities of Transcenta Holding Limited (2023 - 2019)

Year Total Liabilities Total Liabilities Growth
2023 665.66 Million CNY 0.76%
2022 660.64 Million CNY 14.03%
2021 579.38 Million CNY -80.07%
2020 2.9 Billion CNY 32.03%
2019 2.2 Billion CNY 0.0%

Peer Total Liabilities Comparison of Transcenta Holding Limited

Name Total Liabilities Total Liabilities Difference
Uni-Bio Science Group Limited 152.81 Million HKD -335.594%
CK Life Sciences Int'l., (Holdings) Inc. 7.05 Billion HKD 90.569%